Pulmonx CorporationLUNGNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-8.67%
↓ 243% below average
Average (26q)
6.04%
Historical baseline
Range
High:40.04%
Low:-33.32%
Volatility
1213.8%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -8.67% |
| Q2 2025 | 11.56% |
| Q1 2025 | 18.87% |
| Q4 2024 | 6.86% |
| Q3 2024 | -33.32% |
| Q2 2024 | 33.37% |
| Q1 2024 | 8.06% |
| Q4 2023 | -7.68% |
| Q3 2023 | -26.09% |
| Q2 2023 | 34.26% |
| Q1 2023 | 8.97% |
| Q4 2022 | -10.60% |
| Q3 2022 | 21.48% |
| Q2 2022 | 1.70% |
| Q1 2022 | -4.69% |
| Q4 2021 | 31.72% |
| Q3 2021 | -19.71% |
| Q2 2021 | 15.56% |
| Q1 2021 | 22.73% |
| Q4 2020 | 23.79% |
| Q3 2020 | 40.04% |
| Q2 2020 | -8.88% |
| Q1 2020 | -2.37% |
| Q4 2019 | 14.58% |
| Q3 2019 | -3.65% |
| Q2 2019 | -4.69% |
| Q1 2019 | 0.00% |